154 related articles for article (PubMed ID: 16288020)
1. Magnetic resonance imaging visualization of hyaluronidase in ovarian carcinoma.
Shiftan L; Israely T; Cohen M; Frydman V; Dafni H; Stern R; Neeman M
Cancer Res; 2005 Nov; 65(22):10316-23. PubMed ID: 16288020
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of hyaluronidase activity using a bioactive MRI contrast agent.
Shiftan L; Neeman M
Contrast Media Mol Imaging; 2006; 1(3):106-12. PubMed ID: 17193686
[TBL] [Abstract][Full Text] [Related]
3. Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors.
Hiltunen EL; Anttila M; Kultti A; Ropponen K; Penttinen J; Yliskoski M; Kuronen AT; Juhola M; Tammi R; Tammi M; Kosma VM
Cancer Res; 2002 Nov; 62(22):6410-3. PubMed ID: 12438225
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronidase reduces human breast cancer xenografts in SCID mice.
Shuster S; Frost GI; Csoka AB; Formby B; Stern R
Int J Cancer; 2002 Nov; 102(2):192-7. PubMed ID: 12385018
[TBL] [Abstract][Full Text] [Related]
5. A simple assay for hyaluronidase activity using fluorescence polarization.
Murai T; Kawashima H
Biochem Biophys Res Commun; 2008 Nov; 376(3):620-4. PubMed ID: 18805398
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan fragments generated by sperm-secreted hyaluronidase stimulate cytokine/chemokine production via the TLR2 and TLR4 pathway in cumulus cells of ovulated COCs, which may enhance fertilization.
Shimada M; Yanai Y; Okazaki T; Noma N; Kawashima I; Mori T; Richards JS
Development; 2008 Jun; 135(11):2001-11. PubMed ID: 18434414
[TBL] [Abstract][Full Text] [Related]
7. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent.
Han L; Li J; Huang S; Huang R; Liu S; Hu X; Yi P; Shan D; Wang X; Lei H; Jiang C
Biomaterials; 2011 Apr; 32(11):2989-98. PubMed ID: 21277017
[TBL] [Abstract][Full Text] [Related]
8. The role of hyaluronan in mesothelium-induced motility of ovarian carcinoma cells.
Carpenter PM; Dao AV
Anticancer Res; 2003; 23(5A):3985-90. PubMed ID: 14666707
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive magnetic resonance imaging of transport and interstitial fluid pressure in ectopic human lung tumors.
Hassid Y; Furman-Haran E; Margalit R; Eilam R; Degani H
Cancer Res; 2006 Apr; 66(8):4159-66. PubMed ID: 16618737
[TBL] [Abstract][Full Text] [Related]
10. Human breast-cancer metastasis formation in a nude-mouse model: studies of hyaluronidase, hyaluronan and hyaluronan-binding sites in metastatic cells.
Victor R; Chauzy C; Girard N; Gioanni J; d'Anjou J; Stora De Novion H; Delpech B
Int J Cancer; 1999 Jul; 82(1):77-83. PubMed ID: 10360824
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronidase-1 expression promotes lung metastasis in syngeneic mouse tumor models without affecting accumulation of small hyaluronan oligosaccharides in tumor interstitial fluid.
Schmaus A; Sleeman JP
Glycobiology; 2015 Mar; 25(3):258-68. PubMed ID: 25354852
[TBL] [Abstract][Full Text] [Related]
12. Bacteriophage hyaluronidase effectively inhibits growth, migration and invasion by disrupting hyaluronan-mediated Erk1/2 activation and RhoA expression in human breast carcinoma cells.
Lee JH; Moore LD; Kumar S; Pritchard DG; Ponnazhagan S; Deivanayagam C
Cancer Lett; 2010 Dec; 298(2):238-49. PubMed ID: 20688428
[TBL] [Abstract][Full Text] [Related]
13. [Gadolinium-loaded nanoparticle as a novel molecular imaging contrast agent for magnetic resonance imaging].
Liu LZ; Guo GJ; Zeng MS; Lü YC; Liu XW; Cui CY; Wu PH; Li L
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):240-3. PubMed ID: 17425867
[TBL] [Abstract][Full Text] [Related]
14. Changes in molecular weight of hyaluronan and hyaluronidase activity in uterine cervical mucus in cervical ripening.
Obara M; Hirano H; Ogawa M; Tsubaki H; Hosoya N; Yoshida Y; Miyauchi S; Tanaka T
Acta Obstet Gynecol Scand; 2001 Jun; 80(6):492-6. PubMed ID: 11380283
[TBL] [Abstract][Full Text] [Related]
15. High-Molecular-Weight Hyaluronan Is a Hippo Pathway Ligand Directing Cell Density-Dependent Growth Inhibition via PAR1b.
Ooki T; Murata-Kamiya N; Takahashi-Kanemitsu A; Wu W; Hatakeyama M
Dev Cell; 2019 May; 49(4):590-604.e9. PubMed ID: 31080060
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis.
Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD
J Control Release; 2012 Aug; 162(1):111-8. PubMed ID: 22709587
[TBL] [Abstract][Full Text] [Related]
17. A synthetic cartilage extracellular matrix model: hyaluronan and collagen hydrogel relaxivity, impact of macromolecular concentration on dGEMRIC.
Laurens E; Schneider E; Winalski CS; Calabro A
Skeletal Radiol; 2012 Feb; 41(2):209-17. PubMed ID: 22170182
[TBL] [Abstract][Full Text] [Related]
18. Enzyme-linked hyaluronectin: a unique reagent for hyaluronan assay and tissue location and for hyaluronidase activity detection.
Delpech B; Bertrand P; Maingonnat C; Girard N; Chauzy C
Anal Biochem; 1995 Jul; 229(1):35-41. PubMed ID: 8533892
[TBL] [Abstract][Full Text] [Related]
19. HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor.
Lokeshwar VB; Cerwinka WH; Isoyama T; Lokeshwar BL
Cancer Res; 2005 Sep; 65(17):7782-9. PubMed ID: 16140946
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hyaluronan hydrolysis catalysed by hyaluronidase at high substrate concentration and low ionic strength.
Astériou T; Vincent JC; Tranchepain F; Deschrevel B
Matrix Biol; 2006 Apr; 25(3):166-74. PubMed ID: 16380245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
